Reduced Thyroid Hormone Sensitivity Linked to Higher Thyroid Cancer Risk in Euthyroid Patients: Study Finds Written By Medha Baranwal10 Jun 2025 8:30 PM ISTChina: A recent study conducted by researchers from the School of Medicine at Nankai University, Tianjin, China, highlights a potential new risk...
Old Drugs, New Hope: Review Explores Repurposing Medicines for Rare Diseases Written By Medha Baranwal10 Jun 2025 9:30 AM ISTUK: Rare or uncommon diseases affect 1 in 5000 newborn babies globally, irrespective of geographic, ethnic, or socio-cultural background. Some rare...
Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in stage IV metastatic gallbladder cancer - Dr AVS Suresh Written By Dr AVS Suresh9 Jun 2025 12:00 PM ISTChemotherapy-induced anemia (CIA) is a serious complication in cancer patients, impacting treatment continuity and quality of life. In this video,...
PANDOME Study Supports Pancreatic Cancer Screening in Diabetics Over 50 Written By Medha Baranwal8 Jun 2025 9:15 PM ISTUSA: Preliminary results from the PANDOME study, published in The Journal of Clinical Endocrinology & Metabolism, have spotlighted deteriorating...
Olive Oil Intake May Lower Risk of Hormone Receptor-Negative Breast Cancer: Study Written By Dr Riya Dave6 Jun 2025 8:45 PM ISTA new study has revealed that greater consumption of olive oil can significantly decrease the risk of hormone receptor-negative breast cancer,...
AstraZeneca Calquence based regimens approved in EU for previously untreated chronic lymphocytic leukaemia Written By Ruchika Sharma6 Jun 2025 12:28 PM ISTA fixed-duration regimen of AstraZeneca's Calquence (acalabrutinib) in combination with venetoclax, with or without obinutuzumab, has received...
Bristol Myers Squibb, BioNTech ink pact to co-develop, co-commercialize investigational bispecific antibody for multiple solid tumor types Written By Ruchika Sharma6 Jun 2025 11:30 AM ISTPrinceton: BioNTech SE and Bristol Myers Squibb have announced that the companies have entered into an agreement for the global...
Study Unveils Protein That May Be Responsible for Spread of Pancreatic Cancer Dr. Bhumika Maikhuri6 Jun 2025 8:15 AM ISTA protein called PCSK9 determines how pancreatic cancer cells metastasize to different parts of the body especially the lungs or liver. The findings...
Zydus Lifesciences to acquire India, Sri Lanka rights for Agenus cancer immunotherapy BOT/BAL Written By Ruchika Sharma5 Jun 2025 12:24 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that it has entered into a definitive agreement with Agenus Inc. to acquire India and Sri...
Cancer drug: Dr Reddy's Labs, Alvotech ink pact to codevelop biosimilar candidate to Keytruda Written By Ruchika Sharma5 Jun 2025 10:30 AM ISTHyderabad: Dr Reddy's Laboratories Ltd. and Alvotech, a global biotech company specializing in the development and manufacture of...
Nrf2 identified as a key driver of treatment resistance in osteosarcoma: Study Dr. Kamal Kant Kohli4 Jun 2025 8:30 PM ISTA deeper understanding of osteosarcoma, the most common primary malignant bone tumor affecting children and adolescents, is reshaping strategies for...
Exercise Cuts Cancer Death Risk by Over a Third: Study Finds Dr. Bhumika Maikhuri4 Jun 2025 8:15 AM ISTIn a study published in the New England Journal of Medicine, researchers have provided the most definitive evidence to date that structured exercise...
